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INTRODUCTION:  Port  site  metastasis  after  minimally  invasive  urologic  surgery  is  a rare  event despite  the
widespread  utility  of  laparoscopic  techniques  in the  management  of  urologic  malignancies.  Herein,  we
report  a case  of port  site  metastasis  after robot-assisted  radical  prostatectomy.
PRESENTATION OF  CASE:  A currently  77-year-old  male  patient,  who  was  diagnosed  with  cT2c,  Gleason  7
(4  +  3)  prostate  adenocarcinoma  in  our  clinic  back  in  2009,  had  undergone  robot-assisted  radical  pros-
tatectomy  elsewhere.  Histopathological  examination  revealed  pT3a,  Gleason  9  (4 + 5)  disease.  Lymph
nodes  were  negative,  however  surgical  margins  were  positive  on  the  right  side.  PSA recurred  after
9  months  and maximal  androgen  blockade  was  initiated.  Despite  antiandrogenic  manipulations,  PSA
reached  0.83  ng/ml,  33  months  postoperatively.  Concurrently,  we noticed  a palpable  anterior  abdominal
mass  which  demonstrated  metabolic  hyperactivity  on PET  scanning.  Percutaneous  biopsy  of  the  lesion
conﬁrmed  the  presence  of  metastatic  adenocarcinoma.  PSA  did  not  normalize  after  the  complete  exci-
sion  of the metastatic  focus.  Repeated  PET  scan  revealed  multiple  implants  on the  peritoneal  surfaces  of
various  organs.
DISCUSSION:  Port  site  and  peritoneal  metastasis  of  prostate  cancer  after  robot-assisted  radical  prosta-
tectomy  has  not  been  reported  so  far. This peculiar  dissemination  pattern  is most  probably  the result  of
tumor  biology  and  perioperative  factors.
CONCLUSION: Although  encountered  extremely  rarely,  surgeons  should  be aware  of  the  possibility  of  port
site  and/or  peritoneal  metastases  after  minimally  invasive  radical  prostatectomy.
blish
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. Introduction
Port site metastasis is described as tumor implantation localized
n the abdominal wall at the port of entry of the laparoscopic tro-
ar and it is not associated with diffuse peritoneal carcinomatosis.1
he ﬁrst report of urologic tumor port seeding occurred after a diag-
ostic pelvic lymph node dissection for transitional cell carcinoma
f the bladder.2 However, to the best of our knowledge, port-
ite metastasis after robot-assisted radical prostatectomy has not
een reported so far. Herein, we describe a patient who has devel-
ped port site recurrence as well as multiple peritoneal metastatic
eposits after robot-assisted radical prostatectomy.
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2. Presentation of case
A  66-year-old man  presented with lower urinary tract symp-
toms in 2002. His baseline serum PSA value was 1.9 ng/ml and he
had a mildly enlarged prostate (30 g) which did not harbor anything
suspicious on digital rectal examination. He was offered medi-
cal treatment with alpha-adrenergic antagonists. He came back
for routine follow-up visits every 6 months and his symptoms
improved steadily. However, his serum PSA value showed a pro-
gressive increase and reached 5.6 ng/ml after 2 years. Transrectal
prostate biopsy (TRUS-Bx) ruled out the presence of an underlying
malignancy and he remained on alpha-blockers. Five years later,
his PSA climbed up to 6.8 ng/ml at which time there was  indura-
tion in the right lobe of the prostate. TRUS-Bx was repeated and
this time a multifocal, high grade (Gleason 4 + 3 = 7) prostatic ade-
nocarcinoma was  detected. Bony tissue was  free of metastasis on
scintigraphic imaging. After a thorough discussion about the treat-
ment options and considering his age at that moment (70 years
ense.old), we  offered him radiotherapy combined with anti-androgens.
However, he opted for surgical treatment and he underwent
transperitoneal, robot-assisted laparoscopic radical prostatectomy
in another country. According to the discharge summary of the
s Ltd. Open access under CC BY-NC-SA license.
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along with better cosmetic results are the main advantages of min-
imally invasive procedures. However, no oncologic beneﬁt for aig. 1. Axial abdominal MR  image demonstrating the presence of a mass (red arrow)
ocated within the muscular layer of the anterior abdominal wall.
nstitution where the surgery was carried out, the perioperative
nd early postoperative period was uneventful. Histopathological
xamination revealed pT3a, Gleason 4 + 5 = 9 disease with a posi-
ive surgical margin on the right apex. Obturator and iliac lymph
odes were free of tumoral inﬁltration. The patient received no
djuvant treatment and PSA reached a nadir value (<0.02 ng/ml) 3
onths postoperatively. However, after 9 months, PSA started to
limb above 0.2 ng/ml. Metastatic work-up revealed negative ﬁnd-
ngs and we recommended radiotherapy and hormonal treatment.
owever the patient refused radiation treatment and received only
aximal androgen blockade with an LH–RH agonist and a non-
teroidal antiandrogen. After a brief biochemical response, PSA
tarted to rise again and it reached 0.67 ng/ml 21 months post-
peratively, despite second-line hormonal manipulation. In the
eantime, a small palpable mass situated superﬁcially in the ante-
ior abdominal wall came to attention. Abdominal MRI  conﬁrmed
he presence of a round, homogenous anterior abdominal mass
Fig. 1) measuring 5 cm in its greatest dimension. This location
as consistent with the right-hand port site. After documenting
etabolic hyperactivity on FDG-PET scanning (Fig. 2), we sam-
led the lesion and histopathologic outcome was consistent with
etastatic adenocarcinoma. Thirty-three months postoperatively,
hen the PSA was 0.83 ng/ml, we excised the lesion completely
ith clear margins (Fig. 3). The tumor was located within the ante-
ior abdominal musculature, adjacent to the parietal peritoneal
ayer (Fig. 4). Skin and subcutaneous tissues did not contain any
ig. 2. FDG-PET image demonstrating a hypermetabolic mass on the lateral border
f the rectus muscle.Fig. 3. Macroscopic view of the excised specimen. Intramuscularly located lesion
(encircled in red) was removed together with the overlying skin and subcutaneous
tissue.
malignant lesion. Seven months after this operation, during which
he kept on receiving maximal androgen blockade, he developed
low back pain and concurrently his serum PSA value rised to the
level of 1.2 ng/ml. Repeated FDG-PET scan demonstrated the pres-
ence of multiple, milimetric, metastatic hypermetabolic implants
along the peritoneal surface of various organs; namely right lobe
and dome of liver, ascending colon, ureter and cecum (Fig. 5a
and b). We  then decided to add abiraterone acetate to the treat-
ment regimen which showed its effect after 2 months with a mild
PSA response (1.2–0.89 ng/ml). However, PSA bounced back up
to 2.2 ng/ml after 6 months and eventually he was scheduled for
chemotherapy.
3. Discussion
Shorter convalescence and decreased analgesic requirements,minimally invasive approach over open-surgical resection of cancer
has been established.3–5 For this reason, careful patient selection
Fig. 4. High grade (Gleason 4 + 4 = 8) metastatic prostate adenocarcinoma that has
inﬁltrated the striated muscle layer (thick arrow) of the abdominal wall. The deposit
lies in close proximity to the parietal peritoneum (thin arrow). Skin and subcuta-
neous tissues were free of tumoral inﬁltration (not shown in this ﬁgure). Original
magniﬁcation 40×, hematoxylin and eosin stain.
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nig. 5. a and b: FDG-PET scan revealing the presence of hypermetabolic foci located
s critical to keep tumor seeding to a minimum. Dobronte et al.
eported the ﬁrst case of port site metastasis after a laparoscopic
rocedure in 1978. Malignant ascites, that was originating from an
varian cystadenoma, was the most probable source of spread in
hat particular patient.6 The reported overall incidence of tumor
eeding and port site metastasis in the literature ranges from 0.6%
o 21%.3,7 Micali et al. reviewed a total of 18,750 laparoscopic proce-
ures, of which 10,912 were for cancer, and reported the incidence
f port site seeding and peritoneal spread to be 0.09% (10 cases)
nd 0.03% (3 cases), respectively.8 As a conclusion, they stated that
umor seeding after laparoscopic oncologic surgery is very rare and
oes not appear to be greater than that historically reported for
pen surgery.8
The ﬁrst case of port site metastasis involving a urologic proce-
ure was reported in 1994 after lymphadenectomy for transitional
ell carcinoma of the bladder.2 In a recent review by Castillo
t al., which covered 17 studies reported in English literature, a
otal of 31 cases of port site metastasis or tumor seeding sec-
ndary to laparoscopic urologic procedures in the past 20 years
ave been identiﬁed.9 The reported operation types in this review
ncluded nephrectomy, nephroureterectomy, cystectomy, pelvic
ymph node dissection and retroperitoneal lymph node dissection
ut not radical prostatectomy.
Larrousse  et al. reported a port site/subcutaneous recurrence
n a patient with mucinous adenocarcinoma who had under-
one laparoscopic radical prostatectomy and partial cystectomy
xtraperitoneally.10 Savage et al. were the ﬁrst to report a case of
onventional prostate cancer with multiple port site metastases
fter laparoscopic radical prostatectomy. That patient also devel-
ped lymph node recurrence and widespread bony metastases,
ith a PSA of 1.15 ng/mL, likely representing poorly differentiated
rostate cancer.11
Multiple theories have attempted to explain the probable mech-
nisms of port site metastases. Tumor related (high grade cancer),
ound related (local immune response) and procedure related
morcellation, absence of bag retrieval) factors would appear to
acilitate tumor seeding during laparoscopic surgery.3,7,12–14 Port
ite metastasis after laparoscopic radical prostatectomy most likely
esults from a combination of these factors.
To the best of our knowledge, our case is the ﬁrst example of
 port site/peritoneal recurrence of prostate cancer after robot-
ssisted laparoscopic prostatectomy. Theoretically, it should be the
esult of the same multifactorial etiology that has been proposed
bout pure laparoscopic surgery. However, the peritoneal spread
f metastatic lesions after the discovery of the anterior abdomi-
al, intramuscular mass was noteworthy, especially in the absence various peritoneal surfaces (dome of the liver and right ureter in these ﬁgures)
of  bony lesions. The locally advanced, high-grade disease and its
unpredictable biologic behavior should be accepted as the primary
underlying factor. We  can only speculate about the other possi-
bilities such as; the rapid cellular turnover of laparoscopic port
sites and peritoneal incisions providing a fertile ground for cancer-
ous cells,15 the incisions that are too large and the trocars that are
inserted in a nonorthogonal fashion allowing turbulent air ﬂow and
facilitating tumoral implantation16 and lastly traumatic specimen
extraction which can be the source of direct mechanical spread.17
4. Conclusion
Port site metastasis and tumor seeding after radical prosta-
tectomy is exceedingly rare. We report the ﬁrst case of port site
recurrence after robot-assisted laparoscopic radical prostatectomy.
The unusual recurrence site and peritoneal dissemination pattern
in this case is most likely the result of tumoral characteristics and
perioperative factors. Careful patient selection and strict adherence
to basic oncologic surgical principles are of utmost importance in
order to prevent such unusual scenarios.
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